Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

The revised European Patent Convention may limit generic drug use, affecting healthcare professionals' treatment choices.

RCS-01 therapy is safe and may improve skin structure by affecting gene expression.

Hair evaluation is crucial for early diagnosis and management of ARCI, as hair loss often indicates severity.

EDA and EDAR are important for hair follicle development in cashmere goats and affect other related genes.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

The research showed that CRISPR/Cas9 can fix mutations causing a skin disease in stem cells, which then improved skin grafts in mice, but more work on safety and efficiency is needed.

The new Brigatinib nanocarrier is more effective against lung cancer cells than the free drug.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

ERULUS controls root hair growth by regulating cell wall composition and pectin activity.

Calcium channels are vital for normal skin function and their dysfunction can lead to skin issues.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

EDA signaling is linked to skin disorders, various cancers, and liver disease.

Pitx2 helps outer root sheath cells differentiate but can't start hair growth on its own.

Some natural compounds from Iris plants can block enzymes related to certain disorders, with a few affecting both targeted enzymes.

SSAT is a key enzyme affecting cell growth and metabolism, with potential but risky use in disease treatment.

Health Education England is moving forward with phase two of their cosmetic intervention project after a successful summit and plans for future training standards.

Overexpression of sPLA2-IIA in mouse skin reduces hair stem cells and increases cell differentiation through JNK/c-Jun pathway activation.

Ruxolitinib helped a patient with alopecia areata regrow hair.

mEphA1 receptor tyrosine kinase is important for skin and hair development and may play a role in certain diseases.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

The artificial skin promotes better wound healing and skin regeneration.

DAB labeling effectively identifies collagen type III and PDGFR in horse skin, but may show false positives.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

PRX01, PRX44, and PRX73 affect root hair growth by interacting with extensins in Arabidopsis.